title: A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.
abstract: Eph receptor tyrosine kinases and ephrin ligands control many physiological and pathological processes, and molecules interfering with their interaction are useful probes to elucidate their complex biological functions. Moreover, targeting Eph receptors might enable new strategies to inhibit cancer progression and pathological angiogenesis as well as promote nerve regeneration. Because our previous work suggested the importance of the salicylic acid group in antagonistic small molecules targeting Eph receptors, we screened a series of salicylic acid derivatives to identify novel Eph receptor antagonists. This identified a disalicylic acid-furanyl derivative that inhibits ephrin-A5 binding to EphA4 with an IC(50) of 3 μm in ELISAs. This compound, which appears to bind to the ephrin-binding pocket of EphA4, also targets several other Eph receptors. Furthermore, it inhibits EphA2 and EphA4 tyrosine phosphorylation in cells stimulated with ephrin while not affecting phosphorylation of EphB2, which is not a target receptor. In endothelial cells, the disalicylic acid-furanyl derivative inhibits EphA2 phosphorylation in response to TNFα and capillary-like tube formation on Matrigel, two effects that depend on EphA2 interaction with endogenous ephrin-A1. These findings suggest that salicylic acid derivatives could be used as starting points to design new small molecule antagonists of Eph receptors.
authors.affiliation: Sanford-Burnham Medical Research Institute, La Jolla, CA 92037, USA. elenap@sanfordburnham.org
authors.forename: Roberta
authors.initials: R
authors.lastname: Noberini
authors.forename: Surya K
authors.initials: SK
authors.lastname: De
authors.forename: Ziming
authors.initials: Z
authors.lastname: Zhang
authors.forename: Bainan
authors.initials: B
authors.lastname: Wu
authors.forename: Dhanya
authors.initials: D
authors.lastname: Raveendra-Panickar
authors.forename: Vida
authors.initials: V
authors.lastname: Chen
authors.forename: Jesus
authors.initials: J
authors.lastname: Vazquez
authors.forename: Haina
authors.initials: H
authors.lastname: Qin
authors.forename: Jianxing
authors.initials: J
authors.lastname: Song
authors.forename: Nicholas D P
authors.initials: ND
authors.lastname: Cosford
authors.forename: Maurizio
authors.initials: M
authors.lastname: Pellecchia
authors.forename: Elena B
authors.initials: EB
authors.lastname: Pasquale
mesh_terms: D000818:Animals; D001665:Binding Sites; D002460:Cell Line; D036342:Ephrins / Q000378:metabolism*; D000882:Haplorhini; D006801:Humans; D051379:Mice; D008958:Models, Molecular; D011485:Protein Binding / Q000187:drug effects*; D036081:Receptors, Eph Family / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism*; D012459:Salicylates / Q000737:chemistry* / Q000494:pharmacology*
chemical_list: D036342:Ephrins; D012459:Salicylates; D036081:Receptors, Eph Family; C014182:salicylsalicylic acid